Physician profile
Anna Irwin
NPI 1093007643
$29,865.77
in general payments reported to CMS, 2019-2025
30 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2021: $493 · 2022: $1,851 · 2023: $4,345 · 2024: $22K · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $9,013 · Travel and Lodging: $8,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,250.00 |
| Food and Beverage | $9,013.16 |
| Travel and Lodging | $8,086.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $18,521.66 | 2023-2024 | Mild Device Kit |
| Medtronic, INC. | $3,516.00 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Boston Scientific Corporation | $2,030.89 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, Intracept Rf Probe |
| Abbott Laboratories | $1,413.30 | 2022-2025 | Proclaim, Eterna |
| Stryker Corporation | $1,091.87 | 2019-2024 | Mild Device Kit |
| Mml US, INC. | $740.87 | 2022 | |
| Nuvasive, INC. | $528.09 | 2022-2023 | Modulus, Reline, Attrax |
| Nevro Corp. | $378.59 | 2023-2024 | Senza |
| Abbvie INC. | $235.41 | 2022-2025 | |
| Relievant Medsystems, INC. | $146.82 | 2023 | Intracept |
| Scilex Pharmaceuticals INC. | $113.73 | 2022-2024 | Ztlido |
| Lundbeck LLC | $112.44 | 2025 | Vyepti |
| Nalu Medical, INC. | $105.80 | 2023-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $102.05 | 2021 | |
| Averitas Pharma INC. | $99.78 | 2023-2025 | Qutenza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $97.72 | 2024-2025 | |
| Grt US Holding, INC. | $90.27 | 2021-2022 | |
| Biotronik Nro, INC. | $65.85 | 2023-2025 | Prospera, Biotronik |
| Biohaven Pharmaceutical Holding Company Ltd. | $56.35 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $54.06 | 2025 | |
| Painteq LLC | $49.38 | 2024 | Painteq |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Medtronic USA, INC. | $48.08 | 2019 | |
| International Rehabilitative Sciences, INC | $43.78 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
| Collegium Pharmaceutical, INC. | $43.18 | 2022-2024 | Belbuca |
| Almatica Pharma LLC | $39.49 | 2022-2023 | Gralise |
| Axsome Therapeutics, INC. | $32.36 | 2025 | Symbravo |
| Saluda Medical Americas, INC. | $25.18 | 2024 | Evoke |
| Pfizer INC. | $21.00 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $12.77 | 2023 | Zilretta, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Irwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.